| --- |
| license: cc-by-4.0 |
| task_categories: |
| - tabular-classification |
| language: |
| - en |
| tags: |
| - laboratory |
| - HIV |
| - viral-load |
| - CD4 |
| - ART-monitoring |
| - synthetic |
| - sub-saharan-africa |
| pretty_name: HIV Viral Load & CD4 Testing |
| size_categories: |
| - 10K<n<100K |
| configs: |
| - config_name: vl_accessible |
| data_files: data/hiv_vl_cd4_vl_accessible.csv |
| - config_name: vl_limited |
| data_files: data/hiv_vl_cd4_vl_limited.csv |
| default: true |
| - config_name: no_vl_access |
| data_files: data/hiv_vl_cd4_no_vl_access.csv |
| data_type: synthetic |
| --- |
| |
| > ⚠️ **Synthetic dataset** — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference. |
|
|
| # HIV Viral Load & CD4 Testing |
|
|
| ## Abstract |
|
|
| Synthetic dataset modeling HIV viral load and CD4 laboratory services across three SSA scenarios. Captures VL/CD4 test availability, platforms (conventional/POC/DBS), results, turnaround times, clinical actions (EAC, regimen switch), and quality indicators. Parameterized from WHO/UNAIDS guidelines and SSA implementation research. |
|
|
| ## Parameterization Evidence |
|
|
| | Parameter | Value | Source | Year | |
| | --- | --- | --- | --- | |
| | VL coverage SSA | 17% to 71% (2015-2019) | Lecher et al. MMWR | 2021 | |
| | VL suppression on ART | 76% SSA | UNAIDS | 2023 | |
| | Conventional VL TAT | 2-6 weeks | Jani et al. Lancet HIV | 2016 | |
| | POC VL TAT | 1-3 hours | Jani et al. | 2016 | |
| | SSA PLHIV on ART | 21M / 25.6M | UNAIDS | 2023 | |
|
|
| ## Validation |
|
|
|  |
|
|
| ## Usage |
|
|
| ```python |
| from datasets import load_dataset |
| ds = load_dataset("electricsheepafrica/hiv-viral-load-cd4", name="vl_limited") |
| df = ds['train'].to_pandas() |
| ``` |
|
|
| ## References |
|
|
| 1. WHO (2023). HIV treatment guidelines |
| 2. UNAIDS (2023). Global HIV statistics |
| 3. Lecher SL et al. (2021). VL monitoring scale-up. *MMWR*. DOI: 10.15585/mmwr.mm7034a2 |
| 4. Jani IV et al. (2016). POC CD4 and VL. *Lancet HIV*. DOI: 10.1016/S2352-3018(15)00236-X |
|
|
| ## License |
|
|
| CC-BY-4.0 |
|
|